PRKAA2 and metabolic syndrome: Dysregulation of the AMPK pathway is considered as a contributing factor to the metabolic abnormalities associated with lipid accumulation and insulin resistance [44] found in metabolic syndrome [45], [46] and type 2 diabetes [44], [47].